The First Ten Years of the Paediatric Regulation

The First Ten Years of the Paediatric Regulation
Your first opportunity to hear the findings of the report of the European Commission’s consultation reviewing 10 years of the European Paediatric regulation



 




Programme developed in cooperation with the European Commission

 

To mark ten years since the Paediatric legislation entered into force, the European Commission (EC) launched a public consultationExternal link icon to get views and feedback from stakeholders, to support the Commission in drafting its second report on the Paediatric Regulation. The objective of the regulation is to improve the health of children in Europe by facilitating the development and availability of age-appropriate medicines for children, and by increasing available information on the use of medicines for children.

The feedback received forms an integral part of the Commission's final report assessing the impact of the Paediatric Regulation on public health and the pharmaceutical industry, which is due to be published late September/October 2017.


B
efore the Paediatric Regulation came into effect in 2007, many medicines authorised in Europe were not studied adequately or authorised in children. This caused difficulties for prescribers and pharmacists treating children, as well as for their patients and carers.

The Regulation introduced sweeping changes into the regulatory environment for paediatric medicines, designed to better protect the health of children in the EU. The main change was the creation and operation of the Paediatric Committee to provide objective scientific opinions on paediatric investigation plans (PIPs), development plans for medicines for use in children.

It is essential for regulatory professionals to keep abreast of these developments as no new drugs can be registered in the EU without a PIP being approved or a waiver/deferral by the EMA’s Paediatric Committee.

This conference includes a Keynote speech by Commissioner Vytenis Andriukaitis - Health & Food Safety, European Commission, followed by European Parliament MEP Françoise  ROSSETÊTE.

Speakers from the EU Commission, EMA, PDCO chair (PEI, Germany), patient groups, EFPIA, consultants engaged by Commission for report and international view will cover:

Findings of the report 
EMA/PDCO view
Economic impact
The Industry view
The Patient view
The International view – FDA/EMA in close cooperation on paediatrics

There will be ample time to debate in an extended panel session for which questions will be invited in advance from delegates.

Who should attend:

Senior and middle management  regulatory staff.  Heads of regulatory affairs, directors of regulatory policy/intelligence, senior management, CEOs , Research and Development,  Regulatory staff involved in paediatrics, Patient groups, Regulatory Agencies, Law firms, paediatric research networks, SMEs

To register, please log in or create an account

Please read the training terms and conditions before booking this course. By booking a place on this course you are agreeing to the training terms and conditions.

Conference Price (£):
Member: £550 + VAT
Non-member: £675 + VAT

Those working for regulatory agencies or government agencies or academic institutions: 
Member: £412.50 + VAT
Non Member: £506.25 + VAT
 
Those working for charities or SMEs:
Member: £275 +VAT
Non Member: £337.50 + VAT

Those working for patient groups:
£135 + VAT


Bulk booking discounts are also available. 

For the discount codes please contact meetings@topra.org

- Please note the number of discounted places may be limited.
- All fees are shown in Pounds Sterling and do not include VAT 
- Fee excludes accommodation and travel. The delegate ticket includes refreshments at coffee breaks and buffet lunches (if applicable).

When:
11/21/2017 - 11/21/2017
Where:
Pullman Brussels Centre Midi Hotel
Brussels, Belgium
FieldSet
Your VAT country
Your Vat number
NOTE
If your company VAT number does not appear here or you would like to be invoiced using a different VAT number please email finance@topra.org

Sign in or create an account to book this course

Our policy on photography and video

On occasions, TOPRA takes photographs and videos which may be used to help promote our conferences and courses (both online and in print). By purchasing a ticket to attend this meeting you are confirming that you are aware of this and have no objections to your image or voice appearing in any material issued by TOPRA after the meeting.

However, if for any reason you do not wish TOPRA to use your image or voice please let us know.

Recording and photography by delegates is not permitted.